Headline
The latest stories from AHA Today.
The departments of Health and Human Services and Defense will purchase 1.7 million treatment courses of an investigational antiviral drug for $1.2 billion if the Food and Drug Administration approves or authorizes the therapy, the Biden administration announced.
Medicare will pay about $75 per dose to administer COVID-19 vaccines in a Medicare beneficiary’s home, the Centers for Medicare & Medicaid Services announced.
AHA urged UnitedHealthcare to reverse its decision to retroactively deny coverage effective July 1 for emergency department claims the insurer deems non-emergent.
Compared with the pre-vaccination period of Nov. 29 to Dec. 12, 2020, COVID-19 incidence during April 18 to May 1, 2021, was 69% lower among adults overall, and 79%, 71% and 66% lower among persons aged 65 and over, 50-64 and 18-49, respectively, according to a report released by the Center for…
Friday, June 11, marks the last day to apply for the Environmental Services Department of the Year.
COVID Tech Connect will donate to hospitals and other care facilities up to 15 Samsung Galaxy Tab A devices each to help COVID-19 patients connect with their loved ones.
Retail prices for 260 widely used brand-name prescription drugs last year increased by an average 2.9%, more than twice the general rate of inflation, according to a report released by AARP’s Public Policy Institute.
The Department of Health and Human Services will establish a public-private consortium to increase U.S. production of essential medicines and active pharmaceutical ingredients, the White House announced.
The AHA will connect hospitals and health systems with businesses interested in vaccinating their employees as part of an effort to increase COVID-19 vaccinations across the country, the White House announced.
The Food and Drug Administration approved Biogen’s Aduhelm to treat Alzheimer’s disease, the first new treatment approved for the disease since 2003.